Back to top
more

Elanco Animal Health (ELAN)

(Delayed Data from NYSE)

$25.09 USD

25.09
5,311,693

+0.67 (2.74%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $25.12 +0.03 (0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kinjel Shah headshot

Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?

by Kinjel Shah

We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates billions of dollars in revenues.

Zacks Equity Research

Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Elanco Animal Health (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Kinjel Shah headshot

Merck Loses Around $32B in 3 Months: Time to Sell the Stock?

by Kinjel Shah

Declining estimates and the recent price drop make investors skeptical about holding MRK stock.

Kinjel Shah headshot

Merck (MRK) Falls 10% in 3 Months: Should You Buy the Dip?

by Kinjel Shah

Declining estimates and the recent price drop make investors skeptical about holding Merck's (MRK) stock.

Zacks Equity Research

Merck (MRK) to Buy Curon's Bispecific Antibody Drug for $1.3B

by Zacks Equity Research

Merck (MRK) to acquire worldwide rights to a novel investigational clinical-stage bispecific antibody for treating B-cell-associated diseases. The deal is expected to close by third-quarter 2024.

Zacks Equity Research

Elanco Animal Health (ELAN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Elanco Animal Health (ELAN) delivered earnings and revenue surprises of 25% and 3.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

RadNet (RDNT) Q2 Earnings Match Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 0% and 5.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Elanco Animal Health (ELAN) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Elanco Animal Health (ELAN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.

Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.